CSF1R and neoplasm: The inhibition of the colony-stimulating factor 1 receptor (CSF-1R) implicated in the regulation of tumor-associated macrophages (TAM) whose role in carcinogenesis, resulting from the inhibition of tumor infiltration by leukocytes, confers to Regorafenib an immuno-modulating role.